Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Other Non Operating Income (2021 - 2026)

HeartSciences' Other Non Operating Income history spans 6 years, with the latest figure at $5241.0 for Q1 2026.

  • For Q1 2026, Other Non Operating Income fell 64.24% year-over-year to $5241.0; the TTM value through Jan 2026 reached $17143.0, down 87.34%, while the annual FY2025 figure was $87795.0, 60.67% up from the prior year.
  • Other Non Operating Income reached $5241.0 in Q1 2026 per HSCS's latest filing, up from $2168.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $249349.0 in Q2 2022 to a low of $3.0 in Q4 2023.
  • Average Other Non Operating Income over 5 years is $25294.6, with a median of $2490.5 recorded in 2025.
  • Peak YoY movement for Other Non Operating Income: tumbled 99.9% in 2023, then skyrocketed 657000.0% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $1199.0 in 2022, then plummeted by 99.75% to $3.0 in 2023, then surged by 657000.0% to $19713.0 in 2024, then tumbled by 89.0% to $2168.0 in 2025, then soared by 141.74% to $5241.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Other Non Operating Income are $5241.0 (Q1 2026), $2168.0 (Q4 2025), and $2813.0 (Q3 2025).